Vonoprazan fumarate, a novel potassium-competitive acid blocker, in the management of gastroesophageal reflux disease: safety and clinical evidence to date

JOURNAL ARTICLE published 1 January 2018 in Therapeutic Advances in Gastroenterology

Authors: Kentaro Sugano